Clinical Trials Logo

Hip Fractures clinical trials

View clinical trials related to Hip Fractures.

Filter by:

NCT ID: NCT05144191 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Insignia™ Hip Stem Outcomes Study

Start date: February 7, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.

NCT ID: NCT05142462 Active, not recruiting - Hip Fractures Clinical Trials

Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup

Start date: October 27, 2021
Phase:
Study type: Observational

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

NCT ID: NCT05133648 Active, not recruiting - COVID-19 Clinical Trials

Anesthesia Technique in COVID-19 Positive Hip Fracture Patients

Start date: January 5, 2023
Phase:
Study type: Observational

Patients with COVID undergoing hip fracture repair have high mortality rates. If spinal anesthesia is associated with decreased rates of mortality, this study could provide hypothesis generating data for prospective studies. Investigators hypothesize that spinal anesthesia (SA) is associated with decreased mortality compared to general anesthesia (GA) for patients undergoing hip fracture surgery. The primary objective is to determine for patients undergoing hip surgery with COVID-19 infection, whether SA, as compared to GA, is associated with a lower rate of mortality 30 days postoperatively. The secondary objective is to determine whether SA, as compared to GA, is associated with a lower rate of morbidity 30 days postoperatively. Investigators will be analyzing a data set provided by the National Surgical Quality Improvement Program (NSQIP). Descriptive statistics will be performed. Multivariable logistic regression will be performed for the primary and secondary objectives.

NCT ID: NCT04995822 Active, not recruiting - Hip Fractures Clinical Trials

Post Market Clinical Follow-up of EUROSTEM Femoral Stem

Start date: May 21, 2021
Phase:
Study type: Observational

EUROSSTEM is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSTEM performances and safety

NCT ID: NCT04957251 Active, not recruiting - Hip Fractures Clinical Trials

Anterior vs Posterior Approach for Hip Hemiarthroplasty

Start date: September 28, 2015
Phase: N/A
Study type: Interventional

Randomized trial to evaluate the role of the anterior vs posterior approach regarding hemiarthroplasty of the hip. The Investigators' hypothesis is that the muscle sparing anterior approach may result in improved function in the short term, which may allow shorter hospital stay and quicker return to prior level of function.

NCT ID: NCT04943328 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Cemented TrendHip® - Multicenter PMCF Study on Total Indications

TRESTI
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This Post Market Clinical Follow-Up (PMCF) study to evaluate the performance and safety of the cemented TrendHip® stem in a prospective follow-up study with patients who underwent a hip arthroplasty with the investigational product (representative of usual clinical practice), at two follow-up examinations

NCT ID: NCT04925791 Active, not recruiting - Hip Fractures Clinical Trials

Does Limb Pre-Conditioning Reduce Pain After Hip Arthroscopy

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the utilization of Ischemic Pre-Conditioning 24-hours prior to hip arthroscopy decreases patient's post-operative pain and opioid consumption.

NCT ID: NCT04809714 Active, not recruiting - Hip Fractures Clinical Trials

The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The investigators aim to study the use of blood flow restriction therapy (BFR) to augment routine post-operative physical therapy in elderly patients (age >= 65) after recovering from surgical treatment of hip fractures.

NCT ID: NCT04777136 Active, not recruiting - Frailty Clinical Trials

Home-visits From geRiatric tEam aFter hIp fracTure

REFIT
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The primary objective is to examine the effect of multidisciplinary geriatric team home-visits as follow-up after a hip fracture in old patients. The hypothesis is that home-visits will reduce the number of falls, readmissions, prevent functional decline, optimize that medical treatment, and a higher degree of satisfaction and quality of life.

NCT ID: NCT04748354 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Reducing Fall Risk Post Hip Fracture in Mild Cognitive Impairment

Start date: May 3, 2021
Phase: N/A
Study type: Interventional

Hip fracture is recognized as one of the most serious consequences of osteoporosis, less than half regain pre-fracture independence. 95% of all hip fractures in older adults are due to falls. Thus, reducing fall risk while restoring function post-hip fracture is critical. Many with fall-related hip fractures have cognitive impairment; cognitive impairment increases the risk of falls. The purpose of this 6-month proof-of-concept randomized controlled trial (RCT) is to assess the efficacy of the home-based Otago Exercise Program (OEP) compared with usual care in reducing fall risk among older adults with mild cognitive impairment (MCI) and a fall-related hip fracture.